Survival of patients with severe congestive heart failure treated with oral milrinone.
暂无分享,去创建一个
E. Braunwald | E. Braunwald | D. Baim | B. Ransil | W. Grossman | W. Colucci | E. Monrad | H. S. Smith | R. Wright | A. Lanoue | D. Gauthier
[1] S. Geraci,et al. Electrophysiologic effects of milrinone in patients with congestive heart failure. , 1986, The American journal of cardiology.
[2] D. Baim,et al. Assessment of long-term therapy with milrinone and the effects of milrinone withdrawal. , 1986, Circulation.
[3] D. Baim,et al. Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure. , 1986, Circulation.
[4] E. Braunwald,et al. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique. , 1986, Circulation.
[5] R. Cody,et al. Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation. , 1985, Journal of the American College of Cardiology.
[6] H. White,et al. Immediate effects of milrinone on metabolic and sympathetic responses to exercise in severe congestive heart failure. , 1985, The American journal of cardiology.
[7] D. Baim,et al. Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure. , 1985, Circulation.
[8] B. Massie,et al. Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial. , 1985, Circulation.
[9] E. Braunwald,et al. Physiologic assessment of the inotropic, vasodilator and afterload reducing effects of milrinone in subjects without cardiac disease. , 1985, The American journal of cardiology.
[10] C. Furberg,et al. Effect of vasodilators on survival in chronic congestive heart failure. , 1985, The American journal of cardiology.
[11] R. Cody,et al. Acute dose range study of milrinone in congestive heart failure. , 1985, The American journal of cardiology.
[12] E. Braunwald,et al. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. , 1985, The Journal of clinical investigation.
[13] P. Kligfield,et al. Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography. , 1985, The American journal of cardiology.
[14] D. Baim,et al. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone. , 1984, Circulation.
[15] M. Packer,et al. Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure. , 1984, Circulation.
[16] J. Cohn,et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.
[17] M. Moeschberger,et al. Factors influencing the one-year mortality of dilated cardiomyopathy. , 1984, The American journal of cardiology.
[18] E. Braunwald,et al. Evaluating the efficacy of new inotropic agents. , 1984, Journal of the American College of Cardiology.
[19] E. Sonnenblick,et al. Should the failing heart be stimulated? , 1984, The New England journal of medicine.
[20] T. LeJemtel,et al. High prevalence of nonsustained ventricular tachycardia in severe congestive heart failure. , 1984, American heart journal.
[21] C. Antzelevitch,et al. The effects of milrinone on conduction, reflection, and automaticity in canine Purkinje fibers. , 1984, Circulation.
[22] T. Meinertz,et al. Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. , 1984, The American journal of cardiology.
[23] M. Packer,et al. Vasodilator and inotropic therapy for severe chronic heart failure: passion and skepticism. , 1983, Journal of the American College of Cardiology.
[24] E. Braunwald,et al. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure. , 1983, The New England journal of medicine.
[25] R. Ferrari,et al. Cardiotonic Activity of Milrinone, a New and Potent Cardiac Bipyridine, on the Normal and Failing Heart of Experimental Animals , 1983, Journal of cardiovascular pharmacology.
[26] L. Horowitz,et al. Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. , 1983, Journal of the American College of Cardiology.
[27] E. Sonnenblick,et al. Long-term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in cardiac performance and progression of the underlying disease. , 1983, Journal of the American College of Cardiology.
[28] E. Sonnenblick,et al. Sustained Hemodynamic and Clinical Effects of a New Cardiotonic Agent, WIN 47203, in Patients with Severe Congestive Heart Failure , 1983, Circulation.
[29] J. Cohn,et al. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. , 1983, The American journal of cardiology.
[30] R. Magorien,et al. The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathy. , 1983, American heart journal.
[31] J. Halperin,et al. Determinants of clinical response and survival in patients with congestive heart failure treated with captopril. , 1982, American heart journal.
[32] B. Greenberg,et al. Results of Long‐term Vasodilator Therapy in Patients with Refractory Congestive Heart Failure , 1981, Circulation.
[33] W. J. Dixon,et al. BMDP-79, biomedical computer programs, P-series , 1981 .
[34] V. Fuster,et al. The natural history of idiopathic dilated cardiomyopathy. , 1981, The American journal of cardiology.
[35] B. Massie,et al. Long‐term Vasodilator Therapy for Heart Failure: Clinical Response and its Relationship to Hemodynamic Measurements , 1981, Circulation.
[36] A. Katz. A new inotropic drug: its promise and a caution. , 1978, The New England journal of medicine.
[37] W. Kannel,et al. The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.
[38] D. Littmann. The natural history of congestive heart failure. , 1971, The New England journal of medicine.
[39] N. Breslow. A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship , 1970 .
[40] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[41] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .